Patent Assignment
Reel/Frame 029939/0001
Merger
Recorded: 2013-03-07
Pages: 86
Assignor
MSD OSS B.V.
Executed: 2013-01-01
Assignee
ORGANON BIOSCIENCES NEDERLAND B.V.
KLOOSTERSTRAAT 6, AB OSS, 5349, NETHERLANDS
Covered Properties
(185)
Process for the preparation of 7alpha-methylsteroids
Application:
10/502,259 →
Publication:
US US20050090476A1
X-Ray Visible Drug Delivery Device
Drug Delivery System Based on Polyethylene Vinylacetate Copolymers
Pharmaceutical composition comprising a salt of mirtazapine
Application:
11/547,152 →
Publication:
US US20070111993A1
Applicator for Inserting an Implant
Applicator for Inserting an Implant
Method of Treatment of Hormone Depletion Induced Vasomotor Symptoms
Application:
11/917,456 →
Publication:
US US20090306046A1
Regimens for Controlled Drug Delivery Devices for Contraception
Application:
11/917,485 →
Publication:
US US20080206310A1
Regimens for Oral Monophasic Contraceptives
Application:
11/917,492 →
Publication:
US US20080207571A1
Accurate Method to Assess Disease Severity in Clinical Trials Concerning Psychopathology
Application:
12/056,741 →
Publication:
US US20090024003A1
Non-Steroidal Compounds Useful as Glucocorticoid Receptor Modulators
Method for the Preparation of an Enantiomer of a Tetracyclic Benzazepine
Application:
12/098,662 →
Publication:
US US20080255348A1
Kit for and Method of Assembling an Applicator for Inserting an Implant
Drug Delivery System
Stereoselective Synthesis of (S)-1-Methyl-3-Phenylpiperazine
Application:
12/304,557 →
Publication:
US US20100036126A1
Purines as Pkc-Theta Inhibitors
Application:
12/445,862 →
Publication:
US US20110046131A1
Oral Contraceptive Spray
Application:
12/518,732 →
Publication:
US US20100105641A1
Mineralocorticoid Receptor Antagonists
Application:
12/593,746 →
Publication:
US US20100120736A1
Helically-Shaped Drug Delivery System
Application:
12/594,169 →
Publication:
US US20100136090A1
Tsh Receptor Antagonizing Tetrahydroquinoline Compounds
Tricyclic Heterocyclic Derivatives
Application:
12/678,184 →
Publication:
US US20100210680A1
Intrauterine System
Apparatus and Method for Preserving Mucosa
Application:
12/841,864 →
Publication:
US US20110020177A1
Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines
Dihydro)Pyrrolo[2,1-A]Isoquinolines
Novel Androgens
Application:
12/887,607 →
Publication:
US US20110009428A1
PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
Application:
12/936,604 →
Publication:
US US20110218189A1
Indane Derivatives as Ampa Receptor Modulators
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Application:
13/049,139 →
Publication:
US US20110166363A1
1-(4-Ureidobenzoyl)Piperazine Derivatives
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]-Oxepino[4,5-C]Pyrrole
Antibodies Against a Proliferating Inducing Ligand (April) and Methods of Use Thereof
Conjugates of a Polypeptide and an Oligosaccharide
Application:
13/227,910 →
Publication:
US US20120039843A1
Tricyclic Heterocyclic Derivatives
Isoxazole-5-Carboxamide Derivatives
Application:
13/256,553 →
Publication:
US US20120071481A1
Isoxazole-5-Carboxamide Derivatives
Application:
13/256,561 →
Publication:
US US20120095002A1
Process to Form an Orally Disintegrating Tablet for Human Use
2-(1,2-Benzisoxazol-3-Yl)Benzylamine Derivatives
Antithrombotic Dual Inhibitors Comprising a Biotin Residue
1H-[1,2,3]Triazolo[4,5-C]Pyridine-4-Carbonitrile Derivatives
S-Mirtazapine for the Treatment of Hot Flush
Application:
13/570,481 →
Publication:
US US20120302552A1
Intrauterine Deposit
Application:
13/622,031 →
Publication:
US US20130014763A1
Spike Retainer System
Patent:
5,472,434 →
Application:
08/061,031 →
Low Steroid Dose Dry Pharmaceutical Preparation
Patent:
5,382,434 →
Application:
08/216,236 →
Pharmaceutical Granulate
Patent:
5,527,543 →
Application:
08/366,348 →
Lyospheres Comprising Gonadotropin
Patent:
5,656,597 →
Application:
08/454,333 →
Method for Preparing 213 Bi for Therapeutic Use
Patent:
5,641,471 →
Application:
08/527,296 →
Antiglucocorticoid Steroids for the Treatment of Anxiety Disorders
Patent:
5,741,787 →
Application:
08/581,631 →
Sublingual or Buccal Pharmaceutical Composition
Patent:
5,763,476 →
Application:
08/693,064 →
Dna Encoding
Patent:
7,060,490 →
Application:
08/826,361 →
Benzylamine Derivatives Which Are Useful in Treating Psychiatric Disorders
Patent:
6,080,773 →
Application:
08/950,359 →
Method of Preparing a Monoclonal Antibody
Patent:
6,020,170 →
Application:
08/985,898 →
Steroid Compounds Having Contraceptive and Anti-Osteoporsis Activity
Patent:
6,077,873 →
Application:
09/026,348 →
Process for the Microbial Conversion of Phytosterols to Androstenedione and Androstadienedione
Patent:
6,071,714 →
Application:
09/048,432 →
Drug Delivery System for Two or More Active Substances
Patent:
5,989,581 →
Application:
09/056,700 →
Tetrahydroimidazo[2,1-A]Isoquinoline Derivatives
Patent:
5,994,366 →
Application:
09/104,563 →
Isolated Human Bmp-4 Promoter Region
Patent:
6,159,696 →
Application:
09/308,406 →
Benzylamine Derivatives Which Are Useful in Treating Psychiatric Disorders
Patent:
6,313,139 →
Application:
09/359,284 →
Therapeutic Combinations of Mirtazapine and Antipsychotic Agents, for the Treatment or Prophylaxis of Psychotic Disorders
Patent:
6,150,353 →
Application:
09/380,723 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent:
6,194,409 →
Application:
09/403,327 →
Method of Preparing a Monoclonal Antibody, a Pharmaceutical Composition and a Diagnastic Reagent
Patent:
6,392,020 →
Application:
09/405,745 →
Gonadotropin Releasing Hormone Antagonist
Patent:
6,653,286 →
Application:
09/446,324 →
Process for the Production of Heparin
Patent:
6,232,093 →
Application:
09/462,223 →
Solid Phase Supports
Patent:
6,486,354 →
Application:
09/485,613 →
Steroid compounds having contraceptive and anti-osteoporosis activity
Patent:
6,313,180 →
Application:
09/538,783 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent:
6,444,672 →
Application:
09/550,954 →
Drug of Improving Optic Nerve Head Circulation Disorder
Patent:
6,387,910 →
Application:
09/601,231 →
Estrogen Receptor Beta
Patent:
6,680,368 →
Application:
09/608,088 →
Derivatives of azetidine and pyrrolidine
Patent:
6,281,243 →
Application:
09/622,705 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent:
6,432,955 →
Application:
09/679,232 →
Method for identifying Ligand of estrogen receptor beta
Patent:
6,713,270 →
Application:
09/711,288 →
Antithrombotic Compounds
Patent:
6,486,129 →
Application:
09/719,841 →
Aminomethylcarboxylic Acid Derivatives
Patent:
6,410,592 →
Application:
09/744,520 →
Folliculogenesis
Patent:
6,660,717 →
Application:
09/856,995 →
Compounds of Azetidine and Pyrroline
14-Beta,17-Alpha-Hydroxymethylandrostane Derivatives as Androgens
Patent:
6,881,728 →
Application:
09/890,845 →
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Patent:
6,569,863 →
Application:
09/937,416 →
Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
Patent:
7,265,099 →
Application:
10/049,393 →
Spiro(2H-1-Benzopyran-2,4-Piperidine)Derivates as Glycine Transport Inhibitors
Patent:
6,645,973 →
Application:
10/130,557 →
6-Mercapto-Cyclodextrin Derivatives:Reversal Agents for Drug-Induced Neuromuscular Block
Patent:
6,670,340 →
Application:
10/148,307 →
Antithrombotic Compound
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Process for the Preparation of Peptides
Electronic Alarm Timer for Use with a Medical Regimen
Patent:
7,369,463 →
Application:
10/203,196 →
Use of Mirtazapine for the Treatment of Sleep Disorders
Chroman Derivatives as Estrogenic Compounds
Full Length Human HCN1IH Channel Subunit and Variants
16,17-Carbocyclic Condensed Steroid Compounds Having Selective Estrogenic Activity
10-Aryl-11H-Benzo[B]Fluorene Derivatives and Analogs for Medicinal Use
Bicyclic Heteroaromatic Compounds
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
14 Beta, 16, 17-Methylene Steroids as Novel Androgens
2-Alkylated-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
(Pyrido/Thieno) - [F] - Oxazepine-5-One Derivatives
Benzoxazepines Derivatives and Their Use as Ampa Receptor Stimulators
Tetrahydroquinoline Derivatives
C-14 Oxidation of Morphine Derivatives
THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
Glycine-Substituted Thieno[2,3-D]Pyrimidines with Combined Lh and Fsh Agonistic Activity
17ALPHA-Hydroxy-14BETA-Steroids with Hormonal Effect
Tetrahydrobenzfluorene Derivatives
1-Arylsulfonyl-3-Substituted Indole and Indoline Derivatives Useful in the Treatment of Central Nervous System Disorders
Substituted 10-Aryl-11H-Benzo[B]Fluourenes and 7-Aryl-5, 6-Dihydro-Benzo[a]Anthracenes for Selective Effects on Estrogen Receptors
Non-Steroidal Progesterone Receptor Modulators
Etonogestrel Esters
1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives
Indoles Useful in the Treatment of Androgen-Receptor Related Diseases
Tetrahydorquinoline Derivatives and Their Use as Fsh Receptor Modulators
Tetrahydroquinoline Derivatives
Drug Delivery System
Method for the Preparation of Enantiomerically Pure Mirtazapine
Tricyclic 1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives as Cannabinoid CB1 Receptor Agonists
(Indol-3-Yl) Heterocycle Derivatives as Agonists of the Cannabinoid CB1 Receptor
Progesterone Receptor Modulators
6-Mercapto-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
Spiro(2H-1BENZOPYRAN-2,4'-Piperidine) Derivates as Glycine Transport Inhibitors
Process for Rapid Solution Synthesis of Peptides
Vinyl Sulphone Modified Polymer
Chroman Derivatives as Estrogenic Compounds
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]Oxepino[4,5-C]Pyrrole
Crystal Form of Asenapine Maleate
Indole Derivatives
4-Phenyl-6-Substituted-Pyrimidine-2-Carbonitrile Derivatives
9-Azabicyclo[3.3.1]Nonane Derivatives
Novel Androgens
2-(Benzimidazol-1-Yl)-Acetamide Bisaryl Derivatives
8-Azabicyclo[3.2.1]Octane Derivatives
Isoquinoline Derivatives
Compounds with Medicinal Effects Due to Interaction with the Glucocorticoid Receptor
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Process for the Preparation of Estrone and/or Estradiol-Derivates
15 Beta-Substituted Steroids Having Selective Estrogenic Activity
Antithrombotic Dual Inhibitors Comprising a Biotin Residue
Heterocyclic Derivatives
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Bicyclic Heteroaromatic Compounds
Conjugates of a Polypeptide and a Pentasaccharide
Non Steroidal Glucocorticoid Receptor Modulators
6-Substituted Isoquinoline Derivatives
2-(1-Oxo-1H-Isoquinolin-2-Yl)Acetamide Derivatives
Quinazolinone and Isoquinolinone Acetamide Derivatives
New Progesterone Receptor Modulators
2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists
Dihydropyridine Derivatives
4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility
4-Phenyl-5-Oxo-1,4,5,6,7,8,- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
4-Phenyl-5-Oxo-1,4,5,6,7,8- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
Benzoxapzepine Derivatives and Their Use as Ampa Receptor Stimulators
Tetrahydrobenzfluorene Derivatives
Crystal Form of Asenapine Maleate
(Pyrido/Thieno)-[F]-Oxazepine-5-One Derivatives
Indole Derivatives
Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label
Method for the Preparation of an Enantiomerically Pure Benzazepine
New Progesterone Receptor Modulators
Selective Enzymatic Amidation of C-Terminal Esters or Acids of Peptides
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
N-Benzyl,N'-Arylcarbonylpiperazine Derivatives
Substituted Thieno[2,3-D]Pyrimidines as Ampa Modulators
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Aminoisoquinoline Thrombin Inhibitor with Improved Bioavailability
(Pyrido/Thieno)-[F]-Oxazepine-5-One Derivatives
Chroman Derivatives as Estrogenic Compounds
Hexafluoroisopropanol Derivatives
(Pyrrolidin-2-Yl)Phenyl Derivatives
1-(Biphenyl-4-Ylmethyl)Imidazolidine-2,4-Dione
1-(4-(Pyridin-2-Yl)Benzyl)Imidazolidine-2,4-Dione Derivatives
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]-Oxepino[4,5-C]Pyrrole
Antibodies to Human Programmed Death Receptor Pd-1
5- Phenyl-Isoxazole-3-Carboxamide Derivatives as TRPV1 Modulators
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Tetrahydronaphthalen-2-Ol Derivatives
Intrauterine Deposit
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
(Dihydro)Imidazoiso[5,1-A]Quinolines
Substituted 16,17-Annellated Steriod Compounds for Use in Womens Healthcare
Dihydrobenzoindazoles
Non-Steroidal Androgens Compounds
Tetrahydroquinoline Derivatives
Timer
Patent:
460,004 →
Application:
29/138,849 →
Applicator for Inserting an Implant
Patent:
551,759 →
Application:
29/242,104 →
Timer
Patent:
472,162 →
Application:
29/160,362 →
Slide Case Tablet Dispenser
Patent:
647,295 →
Application:
29/342,894 →
Slide Case Tablet Dispenser
Patent:
645,658 →
Application:
29/342,896 →
Slide Case Tablet Dispenser
Patent:
645,244 →
Application:
29/342,900 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2010
From: GROEN, MARINUS BERNARD; PETERS, BERNARDUS WYAND MACHIJS MARIE; PLATE, RALF
To: N.V. ORGANON
Reel/Frame 023862/0794 →
Assignment of Assignor's Interest
Jan 28, 2010
From: VAN VLIET, MICHIEL CHRISTIAN ALEXIANDER; KEMPERMAN, GERARDUS JOHANNES; GOEDHEIJT, MARCEL SCHREUDER
To: N.V. ORGANON
Reel/Frame 023862/0870 →
Assignment of Assignor's Interest
Jan 28, 2010
From: SCHOEMAKER, J.H.
To: N.V. ORGANON
Reel/Frame 023862/0909 →
Merger
Dec 1, 2011
From: N.V. ORGANON
To: MSD OSS B.V.
Reel/Frame 027307/0482 →
Merger
Mar 8, 2013
From: ORGANON BIOSCIENCES NEDERLAND B.V.
To: MERCK SHARP & DOHME B.V.
Reel/Frame 029940/0296 →